Atricure Inc. buy JPMorgan Chase & Co.
Start price
11.02.25
/
50%
€29.29
Target price
11.02.26
€49.31
Performance (%)
-9.87%
End price
12.02.26
€26.40
Summary
This prediction ended on 12.02.26 with a price of €26.40. With a performance of -9.87%, the BUY prediction for Atricure Inc. by JPMorgan_Chase___Co_ closed slightly in the red. JPMorgan_Chase___Co_ has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | - | - | - |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $40.00 to $51.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten